These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6985168)

  • 41. [Changes in serum levels of triiodothyronine in dialyzed patients (author's transl)].
    Racek J; Slabý P; Holecek V
    Cas Lek Cesk; 1981 Jun; 120(24):733-5. PubMed ID: 7296619
    [No Abstract]   [Full Text] [Related]  

  • 42. [Disorders of the fibrinolytic capacity in patients with chronic kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Dvorák J; Kott J; Sefrna F; Cepeláková H
    Cas Lek Cesk; 1988 Apr; 127(15):461-3. PubMed ID: 3378251
    [No Abstract]   [Full Text] [Related]  

  • 43. [Blood platelet function before and after dipyridamole in patients on chronic hemodialysis].
    Twardowski Z; Janicka L; Dmoszyńska A; Gutka A; Pluta A; Kowalewski J
    Pol Arch Med Wewn; 1980 Apr; 63(4):383-91. PubMed ID: 7413468
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
    Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
    Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in platelet function in subjects with chronic renal insufficiency treated with periodical hemodialysis].
    Ferri GM; Taccone-Gallucci M; Bongiovanni P; Mazzarella V; Casciani CU
    Minerva Nefrol; 1981; 28(4):471-5. PubMed ID: 7339516
    [No Abstract]   [Full Text] [Related]  

  • 46. [Value of troponin T in patients with advanced chronic kidney failure. Clinical course after beginning hemodialysis].
    Fernández-Reyes MJ; Heras M; Sánchez R; Mon C
    Nefrologia; 2005; 25(5):574-5. PubMed ID: 16392311
    [No Abstract]   [Full Text] [Related]  

  • 47. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
    Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
    Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [L-ascorbic acid and long-term dialysis program].
    Mydlík M; Derzsiová K; Takác M
    Cas Lek Cesk; 1976 Jan; 115(4):115-9. PubMed ID: 1253213
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of L-carnitine on erythropoiesis and blood platelet aggregation in patients with chronic renal failure treated with hemodialysis].
    Kalinowski M; Popławski A; Mazerska M; Daniluk A
    Pol Merkur Lekarski; 1999 Feb; 6(32):76-8. PubMed ID: 10337176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
    Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
    Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Concentration of selected trace elements in the blood of patients with chronic renal failure].
    Adamiec R; Weyde W
    Pol Tyg Lek; 1982 Dec; 37(48):1421-4. PubMed ID: 7183997
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiac troponins in patients with renal failure: what are we measuring and when should we measure it?
    Collinson PO; Gaze DC
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):269-70. PubMed ID: 19454536
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunoreactive endothelin in dialysis patients: diabetics versus non-diabetics.
    Borissova AM; Kirilov G; Nenchev N; Dakovska L; Krivoshiev S; Vaselov E
    Nephrol Dial Transplant; 1994; 9(9):1355-6. PubMed ID: 7816310
    [No Abstract]   [Full Text] [Related]  

  • 55. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of renal failure and dialysis on circulating ghrelin concentration in children.
    Nüsken KD; Gröschl M; Rauh M; Stöhr W; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2156-7. PubMed ID: 15252183
    [No Abstract]   [Full Text] [Related]  

  • 57. Intermittent dialysis in chronic renal failure.
    Q Med Rev; 1970 Oct; 21(2):22-4. PubMed ID: 5508777
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of an easy commercially available software (VISICALC) on a low-cost personal computer (APPLE II PLUS) to assess a dialysis simulation model.
    Vancini C
    Life Support Syst; 1983; 1 Suppl 1():126-8. PubMed ID: 6336391
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma levels of 5-hydroxyindole-acetic acid in chronic renal insufficiency and their effect on platelet aggregation.
    Sebeková K; Opatrný K; Dzúrik R
    Nephron; 1991; 58(2):253-4. PubMed ID: 1714044
    [No Abstract]   [Full Text] [Related]  

  • 60. [Changes in platelet aggregation in patients on a chronic intermittent dialysis program].
    Malý J; Erben J; Pecka M; Jebavý L; Bláha M; Siroký O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):295-306. PubMed ID: 6985168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.